CAROL M. AMERY MD. LIMITED

Company Registration Number:
14782714 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2025

Period of accounts

Start date: 01 May 2024

End date: 30 April 2025

CAROL M. AMERY MD. LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2025

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

CAROL M. AMERY MD. LIMITED

Company Information

for the Period Ended 30 April 2025




Registered office: 23
Cornmill Lane
Bardsey
Leeds
England
LS17 9EQ
Company Registration Number: 14782714 (England and Wales)

CAROL M. AMERY MD. LIMITED

Profit and Loss Account

for the Period Ended 30 April 2025


2025
£
13 months to
30 Apr 2024
£
Turnover 41,397 11,795
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 0 ) ( 173 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 4,812 ) ( 7,277 )
Profit or (Loss) for Period 36,585 4,345

CAROL M. AMERY MD. LIMITED

Balance sheet

As at 30 April 2025


2025
£
13 months to
30 Apr 2024
£
Called up share capital not paid: 0
Fixed Assets: 3,724 2,666
Current assets: 707 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: ( 1,136 )
Net current assets (liabilities): 707 ( 1,136 )
Total assets less current liabilities: 4,431 1,530
Provision for liabilities: ( 0 )
Total net assets (liabilities): 4,431 1,530
Capital and reserves: 4,431 1,530

CAROL M. AMERY MD. LIMITED

Balance sheet continued

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 27 June 2025
And Signed On Behalf Of The Board By:

Name: Caroline Amery
Status: Director

The notes form part of these financial statements

CAROL M. AMERY MD. LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 April 2025

  • 1. Employee Information

    Average number of employees: 0

CAROL M. AMERY MD. LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 April 2025

  • 2. Off balance sheet disclosure

    No